KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CRISPR Therapeutics AG (CRSP) Profit After Tax: 2015-2025

Historic Profit After Tax for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Sep 2025 value amounting to -$106.4 million.

  • CRISPR Therapeutics AG's Profit After Tax fell 23.85% to -$106.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$488.3 million, marking a year-over-year decrease of 103.80%. This contributed to the annual value of -$366.3 million for FY2024, which is 138.43% down from last year.
  • According to the latest figures from Q3 2025, CRISPR Therapeutics AG's Profit After Tax is -$106.4 million, which was up 48.96% from -$208.5 million recorded in Q2 2025.
  • CRISPR Therapeutics AG's 5-year Profit After Tax high stood at $759.2 million for Q2 2021, and its period low was -$208.5 million during Q2 2025.
  • Over the past 3 years, CRISPR Therapeutics AG's median Profit After Tax value was -$106.4 million (recorded in 2025), while the average stood at -$88.3 million.
  • As far as peak fluctuations go, CRISPR Therapeutics AG's Profit After Tax soared by 1,053.13% in 2021, and later slumped by 141.76% in 2024.
  • Over the past 5 years, CRISPR Therapeutics AG's Profit After Tax (Quarterly) stood at -$141.2 million in 2021, then increased by 21.72% to -$110.6 million in 2022, then skyrocketed by 180.80% to $89.3 million in 2023, then crashed by 141.76% to -$37.3 million in 2024, then fell by 23.85% to -$106.4 million in 2025.
  • Its Profit After Tax was -$106.4 million in Q3 2025, compared to -$208.5 million in Q2 2025 and -$136.0 million in Q1 2025.